Table Of ContentAUTHOR INDEX
Agnati L. F. 261, 271 Fabiano C. 313 Le H. H. 433
AguirreJ .A . 261 Faff-Michalak L. 573 Leavitt B. R. 113
Akers R. F. 549 Finiels-Marlier F. 93 Lee E. H. Y. 363
Albrecht J. 573 Fiori A. 45 Lee R. Y. 433
Al-Deen I. H. S. 605 Fowler C. J. 171 Le Gal la Salle G. 355
Andbjer B. 262 Franck J. 221 Le Grevés P. 341
Araki W. 537 Frankhuijzen A. L. 543 Lekman A. 505
Fredman P. 227 Le Peuch C. 93
Bachelard H. S. 495 Fried G. 221 Loctin F. 559
Bailly Y. 425 Fuxe K. 261, 271 Lorentz J.-G. 297
Barbeito L. 593 Lovenberg W. 327
Barnes N. M. 389 Gaitonde M. K. 151, 159 Liibbert H. 433
Belhage B. 475 Garcia L. 51 Liimmen G. 437
Benfenati F. 271 Ghazi H. 407 Luo D. 483
Benjannet S. 103 Gianoulakis C. 103
Benyhe S. 349 Girod R. 559 Maddison J. E. 511
Bernik D. L. 611 Glaser T. 437 Mansson J.-E. 227
Birman S. 87 Gothert M. 437 Matthiessen L. 425, 453
Boni C. 453 Gottfries J. 227 Mattson M. P. 17
Borsodi A. 349 Gozlan H. 413 MayoJ . 61
Bosin T. R. 531 Grieve A. 467 Maysinger D. 113
Bourde O. 25 Griffiths R. 467 Mbikay M. 103
Brodin E. 221 Gudehithlu K. P. 243 Medina J. H. 567
Brooks K. J. 495 Meier E. |
Bruinvels A. 397 Hadjiconstantinou M. 243 Mengod G. 433
Hagberg B. 505 Meunier F.-M. 87
Cain S. T. 549 Hamon M. 413, 425, 453 Miller R. C. 327
Cangiano C. 45 Hansson E. 227 MinamiN. 81
Cardelli P. 45 Hartline D. K. 281, 297 Miquel M.-C. 453
Cascino A. 45 Hauser K. F. 17 Morel N. 355
Ceci F. 45 Hertz L. | Morita K. 71, 81
Chaki S. 335 Hibert M. 397 Mulder A. H. 543
Challiss R. A. J. 207 Hirouchi M. 375 Muramatsu M. 335
Hoflack J. 397 Murray E. 151, 159
Cheng C. H. K. 389
Holman R. B. 367
Chretien M. 103
Nahorski S. R. 207
Commissiong J. W. 445
lentile R. 313 Nakamura S. 537
Costall B. 389
Itoh Y. 135 Naylor R. J. 389
Cross A. J. 159
Cupo A. 483 Neff N. H. 243
Jacobowitz D. M. 517 Neise A. 437
Jansen F. P. 543 Newcomb R. W. 281, 297
Dalia D. A. 243 Johnston G. A. R. 511 Nicolet M. 51
Damgaard I. 475 Nishibori M. 135
Daval G. 425, 453 Kasper G. C. 531 Nomura Y. 247, 255
Dawson R. M. 125 Kaufman H. 601 Nordmann J. J. 297
Depaulis A. 297 Kauppinen R. A. 495 Nquyen H. 433
Dohi T. 71,81 Kia H. K. 425
Dopico A. M. 61 Kilpatrick G. J. 389 Obata K. 213
Doucet E. 453 Kim M. R. 523 Ohkuma S. 375
Dowling M. H. 125 Kimura J. 537 Oishi R. 135
Drian M.-J. 93 Kitamura Y. 247 Okuyama S. 335
Duchemin A.-M. 243 Kitayama S. 71, 81 O'Regan S. 87
Dunant Y. 559 Kuhn D. M. 39 Osborne N. N. 407
Dunlop D. S. 601 Kumagai C. 255 Otomo S. 335
Dunlop J. 467 Kuriyama K. 319, 375
Palacios J. M. 433
El Mestikawy S. 413, 453 Laborde C. 593 Pena C. 567
Eneroth P. 261 Lajtha A. 601 Piva M. A. 567
Index
Poretski M. 125 Shaw G. G. 605 Tyers M. B. 389
Privat A. 93 Shibata O. 327
Pujol J.-F. 25 Siciliano J. 593 Ueda K. 537
Sok D.-E. 523 Ueha T. 319
Reed J. K. 581 de Souza L. R. 581 Usuki-Ito C. 335
Riad M. 413 Squires R. 475
Richards M. H. 327 Staufenbiel M. 433 Varga E. 349
Rieger F. 51 Steinbach J. 235 Veeranna 33
Rios H. 61 Stell W. K. 483 Verdiére-Sahuqué M. 51
Rivas E. A. 611 Stewart M. G. 143 Verge D. 413, 425, 453
Rodriguez de Lores Arnaiz G. 611 Strom R. 45 Villageois A. 51
Rossi Fanelli F. 45 Svennerholm L. 227, 505
Roth G. A. 213 Synguelakis M. 355 Warner M. 445
Routtenberg A. 549 Sziics M. 349 Watson W.E. J. 511
Widdowson P. S. 367
Saederup E. 475 Takei M. 247 Williams S. R. 495
Saeki K. 135 Tanaka §S. 537 Winsky L. 517
Sakurada T. 341 Taranath Shetty K. 33 Wolf W. A. 39
Sbia M. 355 Tenenhouse A. 445 Wollemann M. 349
Schlicker E. 437 Terenius L. 221, 341 Wysmyk-Cybula U. 573
Schliebs R. 143, 235 Tiger G. 171
Schmitt P. 25 Tinner B. 261 Yonemitsu O. 247
Schoffelmeer A. N. M. 543 Tohda M. 255
Schousboe A. 1, 467, 475 Trumpp-Kallmeyer S. 397 Zhao X.-H. 247
Seidah N. G. 103 Tsujimoto A. 71, 81 Zieher L. M. 61
SUBJECT INDEX
N-acetyl-aspartyl-glutamate - effect of lesions on distribution,
593
N-acetyl-aspartyl-glutamate - in rat brain, 593
acetylcholine content - effect of 6-aminonicotinamide, 159
acetylcholine metabolism - effect on vesamicol, 559
acetylcholine release - from rat amygdala slices, 543
acetylcholine - elevation of [ca**],, 74
acetylcholinesterase binding sites - 125
acetylcholinesterase - glycolipid domain, 51
acetylcholinesterase - in Electric eel, 537
acetylcholinesterase - involvement of phosphatidylinositol, 51
acetylcholinesterase - protease activity, 537
adrenal chromaffin cells - release of catecholamines 71,81
age-related changes - in expression of glutamate transporter, 243
allergic encephalomyelitis - clinicopathological responses, 213
allergic encephalomyelitis - immunochemical responses, 213
allergic encephalomyelitis - in animals, 213
6-aminonicotinamide - effect on acetylcholine content, 159
amines - in neuronal differentiation, 2
amino acids - in neuronal differentiation, 2
ammonia - effect on energy metabolism and intracellular pH, 495
AMPA receptors - in chronic hepatic encephalopathy, 511
3H-AMPA binding - in cerebellum, 511
antibodies - to S-HT,, receptors, 413
antidepressants - effect on glutamatergic system, 247
antidepressants - effect upon 3H-MK-801 binding, 247
astrocytes - uptake of sulphur-containing amino acids, 467
astrocytes - effect of neurotransmitters, 6
astroglial cells - characterisation of gangliosides, 227
autophosphorylation - calmodulin-dependent protein kinase II, 271
aziridinium ion - cholinergic toxin, 113
binding of *H-minaprine to brain slices, 335
binding - of 3H-paroxetine, 42
1257_Rolton-Hunter-8-methoxy-2- (N-propyl-N-propylamino)tetralin -
ligand to localise S-HT,. receptors, 426
n-butyl-B-carboline-3-carboxylate - uptake into cerebral cortex,
567
calcitonin gene-related peptide - fragmentation, 341
calcium binding protein - calretinin, 517
calcium - internal stores, 75
calcium/camodulin-dependent protein kinase II, 271
[Ca**], - elevation by various substances, 74
calmodulin-dependent protein kinase II - modulated by ganglioside
GMI, 271
calretinin -"in rat brain, 517
calretinin - radioimmunoassay, 517
carbon dioxide - effect on inositol monophosphate levels, 327
castration - reduced mRNA pituitary protein 7B2, 103
catecholamine release - effect of C-AMP, 71
catecholamine release - from adrenal medulla, 71,81
catecholaminergic mechanisms - in hypothalamus, 261
cerebellum - localisation of 5-HT,, receptors, 425
Xl
Index
cerebellum - noradrenaline content, 61
choline acetyltransferase - subcellular distribution, 151
choline transport - in oocytes, 87
cholinergic receptors - in visual cortex, 143
cholinergic receptors - postnatal development, 143
cholinergic toxin - aziridinium ion, 113
cholinergic transmission - in Torpedo, 559
circadian variation - in spermine and spermidine, 605
convulsions - produced by kainic acid, 235
C-AMP formation - negatively coupled to S-HT,, receptors, 407
- facilitation of catecholamine release, 81
- in catecholamine release, 71
- inhibits Na*,+ K*-ATPase, 81
development - of neurotransmitter signals, 1
development - of neurotransmitters signals, 17
development - of Raphé neurones, 93
diacylglycerol - second messenger, 171
dibutyryl C-AMP - effect on morphology of cells, 255
dopamine release - effect of substance P, 367
dopamine release - from striatum, 367
dynorphin converting enzyme, 221
ecto-ATPase activity - in PC12 cells, 581
electromotoneuron - tubulin localisation, 355
encephalopathy - 2-oxglutarate dehydrogenase activity in
subcellular sites of CNS, 578
encephalopathy - kainate and AMPA receptors in cerebellum, 511
energy metabolism - effect of ammonia, 495
ethanol - effect on GABA, receptor, 319
N-ethylmaleimide - stimulates serotonin and S¢Rp* uptake, 531
expression of sodium dependent choline transport, 87
forskolin - elevation of [Ca**],, 74
GABA receptors - 475
GABA, receptor complex, 319
GABA, receptor - effect of ethanol, 319
GABA, receptor - mRNA, 373
GABA, receptors - in cultures of cerebellar granule cells, 475
GABA, receptors - of high and low affinity, 475
GABA, receptors - regulate transmitter release, 475
GABA, - receptor a, subunit, 373
gallamine - competition for acetylcholinesterase binding sites,
125
ganglioside pattern - in Rett Syndrome, 505
gangliosides GMI - modulates calmodulin-dependent protein kinase
Eby 2 hk
gangliosides - in cerebellum of humans, 505
gangliosides - lacto series, 227
gangliosides - of astroglial cells, 227
gas chromatography-mass spectrometry - of neurotransmitter
contents, 445
glucose-6-phosphate dehydrgenase - subcellular distribution, 151
glutamate transporter - age related change, 243
glutamatergic system - effect of antidepressants, 247
glycolipid - and acetylcholinesterase, 51
GR67330 - 5-HT, receptor ligand, 389
Index
granule cells in culture - GABA, receptor-types, 475
granules - transport, 281
hemicholinium mustard, 113
hemicholinium mustard - effect nullified by monosialganglioside
GM2, 113
histamine-N-methyltransferase + purification and
characterisation, 135
histamine - inhibits release of serotonin and noradrenaline, 437
hypothalamic catecholaminergic mechanisms, 261
5-HT receptors - modelling studies, 397
5-HT,, receptor antibodies, 413
receptors - autoradiographic localisation, 453
receptors - in cerebellum, 425
receptors - in rabbit retina, 407
receptors - localisation, 425
S-HT, receptors - localisation by in situ hybridization, 453
S-HT,. receptors - mRNA, 453
receptors - negatively coupled to C-AMP formation, 407
receptors - visualisation with antibodies, 413
receptor - mRNA localisation, 433
agonists - effect on transporter, 39
receptors - conformation/activity relationship, 397
receptor-subtype - mRNAs, 433
transporter, 39
receptors - in ileum and brain, 389
- receptors, 389
immunoautoradiogaphy - of 5S-HT,, receptors, 413
in_situ hybridization - localisation of 5-HT,, receptors, 453
inositol 1,4,5-triphosphate - second messenger, 171
inositol monophosphate levels - effect of CO, and low potassium,
327
inositol phospholipid breakdown, 207
inositol phospholipid turnover, 171
intracellular pH - effect of ammonia, 495
kainate receptors - in cerebellum of drugs with chronic hepatic
encephalopathy, 511
3H-kainate binding - in cerebellum, 511
kainic acid-induced convulsions, 235
kainic acid-induced convulsions - affect phorbol ester binding
and protein phosphorylation, 235
Kappa opioid receptor - in frog brain, 349
phosphatidylserine,
tyrosine hydroxyl
ntidepressant
397
actions, 1
iediated events,
Index
modulation - of receptor mediated events, 207
monoamines - effect on astrocytes, 6
monocular deprivation - effect on muscarinic receptors in visual
cortex, 143
monosialganglioside GMI - protects lesions produced by
hemicholinium mustard, 113
MRNA for pituitary protein 7B2 - reduced by castration, 103
mRNA - for 5-HT,, receptors, 453
mRNA - for pituitary protein 7B2, 103
mRNA - of GABA, receptors, 373
mRNAs - of different 5-HT receptor-types, 433
uw-opioid receptor activator - inhibits release of acetylcholine,
543
w-opioid receptor activator - inhibits release of noradrenaline,
543
w-opioid receptors - modulation of neurotransmitter release, 543
opioid receptopr - in frog brain, 349
muscarinic receptors - in visual cortex, 143
muscarinic receptors - postnatal development, 143
NAAG - see N-acetyl-aspartyl-glutamate, 593
Na’, K*-ATPase - inhibition by C-AMP, 81
neurones - effect of protein kinase C, 93
neuroendocrine functions - involvement of neuropeptide Y, 261
neurohypophysis - oxytocin-neurophysin processing2,97
neuronal cultures - uptake of sulphur-containing amino acids, 467
neuropeptide converting enzymes, 221
neuropeptide Y receptors, 261
neuropeptide Y receptors - involvement in hypothalamic
catecholamine systems, 261
neuropeptide Y receptors - involvement in neuroendocrine
functions, 261
neurophysin - processing in neurohypophysis, 297
neurotransmitter content - gas chromatography/mass spectrometry,
445
neurotransmitters - as development signals, 1
neurotransmitters - quantification, 445
NG 108-15 cells - effect of dibutyryl C-AMP and phorbol esters,
255
nimodipine - in studies on serotonin and noradrenaline release,
437
NMR - ammonia neurotoxicity, 495
noradrenaline release - from rat amygdala slices, 543
noradrenaline release - inhibition by 5-HT and histamine, 437
noradrenaline - content in postnatal period, 61
noradrenaline - in cerebellum, 61
noradrenaline - induced by x-irradiation, 61
p-nitrophenyl phosphorylcholine-hydrolysing phosphodiesterase -
released by phospholipase C, 523
nuclear magnetic resonance spectroscopy - see NMR, 495
ontogeny - of thiamine pyophosphatase, 33
opioid receptors - effect of 5’-guanylimidodiphosphate, 349
2-oxoglutarate dehydrogenase activity - effect of ammonia, 573
2-oxoglutarate dehydrogenase activity - in cerebellum from
encephalopathy rats, 573
2-oxoglutarate dehydrogenase activity - in subcellular sites of
cerebellum, 573
Index
oxytocin - processing in neurohypophysis, 297
paroxatine - binding, 42
PC12 cells - ecto ATP-ase activity and phosphorylation, 581
peptide - processing, release, compartmentation, 281
phorbol ester binding - effect of kainic acid-induced
convulsions, 235
phorbol ester binding - to protein kinase C, 235
phorbol esters - effect on morphology of cells, 255
phorbol esters - effect on serotonin uptake, 99
phosphatidylinositol - involvement in acetylcholinesterase, 51
phosphatidylserine liposomes - fusion with synaptosomes, 611
phosphoglucose isomerase - subcellular distribution - 151
6-phosphogluconate dehydrogenase - subcellular distribution, 151
phosphoinositide cycle, 171
phospholipase C - releases enzyme, 523
phosphorylation - efect of kainic acid-induced convulsions, 235
pituiary protein 7B2 - mRNA, 103
polyamine interconversion - effect of methylglioxal
bis[guanylhydrazone], 313
polyamine - interconversion in retina, 313
polyamines circadian variations, 605
postnatal development - of muscarinic receptors, 143
postnatal development - of pyruvate dehydrogenase, 549
post-translational processing of retinal proenkephalin, 483
potassium - elevation of [Ca**],, 74
potassium - effect on inositol monophosphate levels, 327
potassium channel - binding of minaprine, 335
proenkephalin - effect of light and dark in chicken retina, 483
proenkephalin - in light and dark adapted retinas, 483
protease activity - associated with acetycholinesterase, 537
protein kinase C - binding of phorbol esters, 235
protein kinase C - involvement in development of neurones, 93
protein synthesis - regulation, 601
pyruvate dehydrogenase - phosphorylation, 549
pyruvate dehydrogenase - postnatal development, 549
pyruvate dehydrogenase - subcellular, 151
R424722 - effect on tyrosine hydroxylase, 25
radioimmunoassay - of calretinin, 517
Raphé neurones - development, 93
Raphé neurones - in culture, 93
86Rpt uptake into platelets - stimulated by N-ethylmaleimide, 531
receptor crosstalk, 171
receptor desensitization, 171
receptor modelling - of 5-HT receptors, 397
receptors - 5-HT, subtype, 389
receptors - linked to inositol phospholipid breakdown, 171
receptors - linked to inositol phospholipid breakdown, 171
receptors - linked to inositolphospholipid breakdown, 207
release - of enzymes caused by phospholipase C, 523
retina - proenkephalin metabolism, 483
retina - polyamines, 313
Rett Syndrome - altered ganglioside patterns, 505
ribosome content - during development, 601
RU 24969 - action on 5-HT transporter, 39
secretory granules - transport, 281
Index
sensorimotor cortex lesions - effect on distribution of N-acetyl-
aspartyl-glutamate, 593
serotonin uptake - effect of phorbol esters, 99
serotonin receptor heterogeneity, 433
serotonin release - inhibition caused by serotonin and histamine,
437
serotonin uptake into platelets - stimulated by N-ethylmaleimide,
531
serotonin - inhibits release of serotonin and noradrenaline, 437
Signals - in development, 1
sodium-dependent choline transport, 87
spermidine content - circadian variation, 605
spermine concentration - circadian variation, 605
substance P endopeptidase, 221
substance P - effect on dopamine release, 367
sulphur-containing amino acids - 467
susbtance P - fragmentation, 341
synaptosomes - fusion with phosphatidylserine liposomes, 605
synthesis of retinal proenkephalin, 483
tacrine - competition for acetylcholinesterase binding sites, 125
temporal integration - of neurotransmitters, 17
tetrahydrobiopterin levels - effect of tryptophan, 363
TFMPP - effect on 5-HT transporter, 39
thiamine pyophosphatase - purification and distribution, 33
thiamine pyrophosphatase - in brain, 33
Torpedo - tubulin in electromotoneurons, 355
toxins - hemicholinium derivatives, 113
transketolase - subcellular distribution, 151
transport - of secretory granules, 281
transporter: = of 5-HT, SS
tryptophan - effect on tetrahydrobiopterin levels, 363
tubulin - in electromotoneurones3,5 5
tyrosine hydroxylase - effect of R424722
tyrosine hydroxylase - in Locus coeruleus, 25
uptake - of n-butyl-fB-carboline-3-carboxylate, 567
uptake - of sulphur-containing amino acids, 467
vesamicol - effect on acetylcholine metabolism, 559
visual cortex muscarinic receptors - effect of monocular
deprivation, 143
Xenopus oocytes - injection of poly A(+) mRNA, 243
x-irradiation - effect on noradrenalne content, 61
PRINTED BY BPCC-AUP ABERDEEN LTD
